Efficacy Study of Chloroquine to Plasmodium vivax Malaria in Darimu and Bure Districts, Southwest Ethiopia

BACKGROUND: Chloroquine (CQ) is the first line treatment for vivax malaria in Ethiopia. However, the therapeutic efficacy of the drug is now declining. Several reports from different areas of the country showed CQ-vivax treatment failure increasing. This study therefore aimed to provide additional d...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeshanew, Solomon, Dagne, Alemayehu, Taye, Behailu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936702/
https://www.ncbi.nlm.nih.gov/pubmed/33688214
http://dx.doi.org/10.2147/IDR.S300692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936702/
https://www.ncbi.nlm.nih.gov/pubmed/33688214
http://dx.doi.org/10.2147/IDR.S300692

Ejemplares similares